Q2037 is a valid 2023 HCPCS Code that could be used to indicate Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) for reimbursement purposes.
Q2037 belongs to Pneumococcal/Flu Vaccine Type of Service and has been in effect since Jan 01, 2014.
Fluvirin vacc, 3 yrs & >, im
Q2037 code information
| HCPCS code: | Q2037 |
| Description: | INFLUENZA VIRUS VACCINE, SPLIT VIRUS, WHEN ADMINISTERED TO INDIVIDUALS 3 YEARS OF AGE AND OLDER, FOR INTRAMUSCULAR USE (FLUVIRIN) |
| Effective Date: | Jan 01, 2014 |
| Added Date: | Jan 01, 2011 |
| Termination Date: | HCPCS Q2037 was terminated on Nov 30, -0001 |
| Pricing indicator: | 54 - VACCINATIONS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | D - SPECIAL COVERAGE INSTRUCTIONS APPLY |
| BETOS code: | O1G - INFLUENZA VACCINE |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
V - PNEUMOCOCCAL/FLU VACCINE
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to Q2037